Moderna prepares for a ‘long-term endemic market’ for Covid-19 vaccines

As the Delta variant of the virus behind Covid-19 grips the world, local vaccine maker Moderna Inc. (Nasdaq: MRNA) is preparing for an endemic future, starting with booster shots.